Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|May 25, 2026
TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infectionMarina Seady, Mark A Maynes, Javonte S Thelwell, et al.Neoplasia (New York, N.Y.)|May 1, 2015
Widespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast CancerSara J Felts, Virginia P Van Keulen, Michael J Hansen, et al.Proceedings of the National Academy of Sciences of the United States of America|February 8, 2019
Breaking tolerance with engineered class I antigen-presenting moleculesChristopher A Parks, Kalli R Henning, Kevin D Pavelko, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2020
Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus InfectionZachariah P Tritz, Robin C Orozco, Courtney S Malo, et al.Journal for Immunotherapy of Cancer|April 5, 2025
MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigensJames William Jenkins, Alvaro Peña, Sarah A Castro, et al.Brain : a Journal of Neurology|November 30, 2020
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediatorsKatayoun Ayasoufi, Christian K Pfaller, Laura Evgin, et al.Brain, Behavior, and Immunity|May 26, 2023
Brain resident memory T cells rapidly expand and initiate neuroinflammatory responses following CNS viral infectionKatayoun Ayasoufi, Delaney M Wolf, Shelby L Namen, et al.Cancer Immunology Research|March 15, 2023
Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I ExpressionZachariah P Tritz, Katayoun Ayasoufi, Delaney M Wolf, et al.Science Advances|August 24, 2022
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2Haley E Mudrick, Shane Massey, Erin B McGlinch, et al.Blood|November 23, 2018
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenograftsRosalie M Sterner, Reona Sakemura, Michelle J Cox, et al.Pageof 7